Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72162-2394

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72162-2394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622394)

Label (Lbl721622394)
This text appears to be a package insert for a medication containing Methylphenidate Hydrochloride in a controlled-release formulation. Each tablet contains 36 mg of the active ingredient. The recommended storage temperature is at 25°C (77°F) with permitted excursions between 15-30°C (59-86°F). The usual dosage is once daily. It also mentions a QR code on the package insert for dosage information and a Medication Guide. The medication is for prescription use only and should be dispensed by a pharmacist to each patient. It is important to keep this and all drugs out of the reach of children.*
FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)
This text provides dosing information for Methylphenidate HCI at 18 mg once daily and Methylphenidate at 5 mg three times daily. It also mentions a table or graph showing the mean plasma Methylphenidate concentration over time (in hours). The information seems to be part of a study or medical prescription regimen.*
FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)
This text provides information about a study involving the administration of Methylphenidate HC once daily and a placebo to participants. It appears to refer to Study 1 and Study 2, but details are limited.*
FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.